EP3800189
Framleiðsla á (S)-N-(5-((R)-2-(2,5-díflúorfenýl)pyrrólidín-1-ýl)pýrasóló[1,5-a]¬pýrimídín-3-ýl)-3-hýdroxýpyrrólidín-1-karboxamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.5.2017EP published:
28.6.2023EP application number:
20208218.6
EP translation filed:
17.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
17.5.2037Expiry date:
17.5.2026Next due date:
31.5.2026
Title in English:
PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDELanguage of the patent:
English
Timeline
Today
18.5.2017EP application
28.6.2023EP Publication
17.7.2023Translation submitted
15.8.2023Registration published
17.5.2026Expires
Owner
Name:
Loxo Oncology, Inc.Address:
281 Tresser Boulevard 9th Floor, Stamford, Connecticut 06901, US
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, Boulder, CO 80301, US
Inventor
Name:
REYNOLDS, MarkAddress:
Stamford, CT 06901, US
Name:
EARY, Charles ToddAddress:
Stamford, CT 06901, US
Name:
SPENCER, StaceyAddress:
Lyons, CO 80540, US
Name:
JUENGST, DerrickAddress:
Boulder, CO 80301, US
Name:
HACHE, BrunoAddress:
Stamford, CT 06901, US
Name:
JIANG, YutongAddress:
Boulder, CO 80301, US
Name:
HAAS, JuliaAddress:
Boulder, CO 80301, US
Name:
ANDREWS, Steven W.Address:
Boulder, CO 80301, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662338359 PDate:
18.5.2016Country:
US
Classification
Categories:
C07D 487/04, A61K 31/5025, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.4.2024
Expires: 17.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.5.2025
Expires: 17.5.2026
Payer: Árnason Faktor ehf.